Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension

Cardiovascular Research

Volumn 82, Issue 3, 2009, Pages 503-512

  Kang, Yu Ming ^a,b,c   Ma, Ying ^c   Zheng, Jin Ping ^c   Elks, Carrie ^b   Sriramula, Srinivas ^b   Yang, Zhi Ming ^c   Francis, Joseph ^b  

^a SHANTOU UNIVERSITY   (China)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Brain; Hypertension; Nuclear factor kappa B; Oxidative stress

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOSARTAN; NORADRENALIN; PYRROLIDINE DITHIOCARBAMATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; TEMPOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC MINIPUMP; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; THALAMUS MIDLINE NUCLEUS;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CYCLIC N-OXIDES; CYTOKINES; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SPIN LABELS; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM; THIOCARBAMATES;

EID: 66249130392     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp073     Document Type: Article

References (37)

1. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995;92:3521-3525.
2. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139:191-202.
3. Simpson JB. The circumventricular organs and the central actions of angiotensin. Neuroendocrinology 1981;32:248-256.
4. Zhu GQ, Gao L, Patel KP, Zucker IH, Wang W. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol 2004;97:1746-1754.
5. Granger JP. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol 2006;290:H923-H924.
6. Phillips MI, Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002;3:569-577.
7. Zhang ZH, Wei SG, Francis J, Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 2003;284: R916-R927.
8. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathway. J Hypertens 2001;19:1245-1254.
9. Li JM, Fan LM, Christie MR, Shah AM. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005;25: 2320-2330.
10. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97: 1916-1923.
11. Megumi F, Katsuyuki A, Ai N, Toshiro F. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007;50:360-367.
12. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004;109:1594-1602.
13. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kB. Cardiovasc Res 2008;79: 671-678.
14. Edgley AJ, Kett MM, Anderson WP. Evidence for renal vascular remodeling in angiotensin II-induced hypertension. J Hypertens 2003;21:1401- 1406.
15. Reckelhoff JF, Zhang H, Srivastava K, Roberts LJ 2nd, Morrow JD, Romero JC. Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats. Hypertension 2000;35:476-479.
16. Kang YM, Ma Y, Guo YL, He RL, Guo ZW, Elks C et al. Activation of microglia in paraventricular nucleus of hypothalamus: a source of central cytokines induced by nuclear factor-kappaB or oxidative stress in hypertension (Abstract). Circulation 2008;118:S295-S296.
17. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 2008;52:679-686.
18. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 2008;294:H1067-H1074.
19. Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yorimitsu M, Yokotani K. Brain nuclear factor kappa B is involved in the corticotropin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats. Eur J Pharmacol 2008;584:207-212.
20. Xu L, Collister JP, Osborn JW, Brooks VL. Endogenous ANG II supports lumbar sympathetic activity in conscious sodium-deprived rats: role of area postrema. Am J Physiol 1998;275:R46-R55.
21. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, Johnson AK et al. Novel effect of mineralocorticoid receptor antagonism to reduce proinflamma-tory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 2006;99:758-766.
22. Guggilam A, Haque M, Kerut EK, McIlwain E, Lucchesi P, Seghal I et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 2007;293:H599-H609.
23. Kang YM, Zhang ZH, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 2008;295:H227-H236.
24. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNFalpha. Am J Physiol Cell Physiol 2004;286:C779-C784.
25. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345-1351.
26. Gorbea-Oppliger VJ, Fink GD. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J Pharmacol Exp Ther 1995;273:611-616.
27. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002;82:12-22.
28. de Wardener HE. The hypothalamus and hypertension. Physiol Rev 2001; 81:1599-1658.
29. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 1997;30:35-41.
30. Cottone S, Vadalà A, Vella MC, Nardi E, Mulé G, Contorno A et al. Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension. Am J Hypertens 1998;11:548-553.
31. Cowling RT, Gurantz D, Peng J, Dillmann WH, Greenberg BH. Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta. J Biol Chem 2002;277: 5719-5724.
32. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-862.
33. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999;189:1839- 1845.
34. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-κB as a potential biomarker for oxidative stress. Br J Nutr 2001 ;86: S121-S127.
35. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Ore Res 2004;95:210-216.
36. Holownia A, Braszko J. The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells. Naunyn Schmiedebergs Arch Pharmacol 2007;376:157-163.
37. Lu D, Yang H, Raizada MK. AT1 receptor-mediated nuclear translocation of Raf-1 in brain neurons. J Neurochem 1998;70:424-427.